Llwytho...
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
OBJECTIVE: We assessed CSF levels of the light chain subunit of neurofilaments (NfL) at baseline and after fingolimod therapy or placebo in patients with relapsing-remitting multiple sclerosis (RRMS). Changes in NfL levels were also correlated with relapse and MRI outcomes. METHODS: CSF samples were...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Neurology |
|---|---|
| Prif Awduron: | , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Lippincott Williams & Wilkins
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4409586/ https://ncbi.nlm.nih.gov/pubmed/25809304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001491 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|